FDA complicates estrogen controversy.
D004348:Drug Labeling; D045166:Estradiol Congeners / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D014481:United States; D014486:United States Food and Drug Administration
D045166:Estradiol Congeners